Menu Search
Equities

Kromek Group PLC

4KM:FRA

Kromek Group PLC

Actions
  • Price (EUR)0.0705
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change+38.24%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 20:50 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Kromek Group plc is a developer of radiation detection and bio-detection technology solutions for the advanced imaging and chemical, biological, radiological, and nuclear (CBRN) detection segments. Its advanced imaging segment comprises the medical, security, and industrial markets. The Company provides its original equipment manufacturer customers with detector components based on its core cadmium zinc telluride (CZT) platform to detect of diseases such as cancer and Alzheimer's, contamination in industrial manufacture and explosives in aviation settings. In CBRN detection, the Company provides nuclear radiation detection solutions to the global homeland defense and security market. Its compact, handheld, high-performance radiation detectors, based on advanced scintillation technology, are primarily used to protect critical infrastructure and urban environments from the threat of dirty bombs. The Company is also developing bio-security solutions in the CBRN detection segment.

  • Revenue in GBP (TTM)19.40m
  • Net income in GBP-3.29m
  • Incorporated2013
  • Employees162.00
  • Location
    Kromek Group PLCNETPark, Thomas Wright WaySEDGEFIELD TS21 3FDUnited KingdomGBR
  • Phone+44 174 062 6060
  • Fax+44 174 062 6061
  • Websitehttps://www.kromek.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.